This inventor holds 5 USPTO granted patents and 1 published patent application, plus 6 CIPO patents and 2 EPO patents. Top assignees: Altus Formulation Inc., Zoetis Services LLC, Bioastra Technologies, Inc.. Active years: 2018-2025.
Location History:
- Montreal, CA (2018 - 2020)
- Montréal, CA (2022)
Company Filing History:
2 out of 4 
2 out of 224 
1 out of 2 Years Active: 2018-2025
Title: Piotr Kujawa: Innovator in Pharmaceutical Polymers
Introduction
Piotr Kujawa is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceutical polymers, particularly through his innovative work on PVP-PLA block copolymers. With a total of 5 patents to his name, Kujawa's inventions are paving the way for advancements in drug formulation and delivery.
Latest Patents
Kujawa's latest patents focus on the development of non-ionic PVP-PLA block copolymers and their applications in liquid pharmaceutical compositions. These block copolymers are characterized by a specific formula where the initiator alcohol has a boiling point greater than 145° C. The polymers demonstrate flexibility in formulating multiple low-solubility active pharmaceutical ingredients (APIs), such as flurbiprofen, celecoxib, acetaminophen, and propofol. His work also includes methods for synthesizing these copolymers, which involve initiating polymerization of D,L-Lactide and controlled polymerization techniques.
Career Highlights
Throughout his career, Kujawa has worked with prominent companies in the pharmaceutical industry, including Zoetis Services LLC and Altus Formulation Inc. His experience in these organizations has allowed him to refine his expertise in polymer chemistry and drug formulation.
Collaborations
Kujawa has collaborated with talented professionals in his field, including Wilms Baille and Sumitra Rajagopalan. These partnerships have contributed to the success of his projects and the advancement of pharmaceutical technologies.
Conclusion
Piotr Kujawa's innovative work in the development of PVP-PLA block copolymers showcases his commitment to improving pharmaceutical formulations. His contributions are essential for the future of drug delivery systems and highlight the importance of innovation in the pharmaceutical industry.